Home > Insider Trading > Filing (0000899243-16-016636)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1285819	Omeros Corp	OMER	Pharmaceutical Preparations (2834)	911663741

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1472158	J. Thomas Cable	201 Elliott Avenue West Seattle WA 98119		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-03-24	1,600	$14.71	49,467	No	4	S	Direct
Common Stock	Disposition	2016-03-24	400	$15.22	49,067	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person on November 21, 2014, at which time the trading schedule, including sale periods and the number of shares to be sold, was established, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. This Rule 10b5-1 plan provides for fixed sales of a total of 8,000 shares over a one-year period beginning March 2015, with sale periods commencing approximately every four months. This sale of 2,000 shares is the result of the fourth and final trade pursuant to this trading plan.
This transaction was executed in multiple trades at prices ranging from $14.1550 to $15.1283; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
This transaction was executed in multiple trades at prices ranging from $15.21 to $15.24; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.